Logo: Community Access National Network (CANN)

Follow Us on Twitter

Friend Us on Facebook

Contact Us

Home About Us ADAP Watch Co-Infection Watch Medicaid Watch Partners Press Releases Programs Public Comments

Community Access National Network

The Community Access National Network (CANN) is a 501(c)(3) national nonprofit organization (formerly incorporated under the "Ryan White CARE Act Title II Community AIDS National Network") focusing on public policy issues relating to HIV/AIDS and Hepatitis C. Its coalition-based work is done on behalf of its patient advocacy groups, pharmaceutical partners and government agencies. We invite you to support our efforts by making a tax-deductible donation today. Please click the "Donations" button on the right to contribute.

Make Your Tax-Deductible Donation Today!

2015 Annual Report

A Year of Accomplishment

The Community Access National Network (CANN) published its 2015 Annual Report. The 2015 Annual Report conveys some key accomplishments and information about the organization.

CLICK HERE to read, "2015 Annual Report"


Do Black Boxes Mean Red Ink for Drug Companies?
By: Marcus J. Hopkins, Blogger

The U.S. Food & Drug Administration (FDA) has recently concluded that new Direct Acting Agents (DAAs) to treat Hepatitis C (HCV) require a boxed warning for the drugs advising clinicians and physicians to screen patients for evidence of a past or current Hepatitis B (HBV) infection before undergoing treatment for HCV. This warning, indicated by black box on the labels of all nine current DAAs, has many investors worried that, along with consistent questions about the Wholesale Acquisition Costs (WACs) of newer HCV drugs, stock prices may face volatility in the coming years.

CLICK HERE to read, "Do Black Boxes Mean Red Ink for Drug Companies?"

Building a Focus on Healthy Aging for Older Adults Living With HIV: A Call to Action

Roundtable Report Released at ACTHIV

More than half of the 1.2 million people living with HIV in the United States are over the age of 50, according to the Centers for Disease Control and Prevention. It is estimated that by 2020, 70 percent of HIV patients will be 50 or older. Advances in HIV treatment have turned what was once considered a death sentence into a manageable chronic disease.

Now that people with HIV are living longer, they are experiencing the impact of age-associated comorbidities and face a host of psychosocial concerns that must be addressed. Given the unique needs of this population, there is a need for increased focus and purposeful action to develop a plan that will allow people with HIV and their health care providers to collectively improve the way that older adults with HIV can expect to age.

This report stems from a discussion among national thought leaders in aging and HIV, convened by Theratechnologies on March 2, 2016, focused on identifying key themes and important next steps to advance actions to improve healthy aging for people with HIV. Click here to read the full report.

CLICK HERE to download, "Building a Focus on Healthy Aging for Older Adults Living With HIV: A Call to Action"

Hepatitis C Therapies Covered by the AIDS Drug Assistance Programs

HIV/HCV Co-Infection Watch

The Community Access National Network (CANN) today published an InfoGraphic, "Hepatitis C Therapies Covered by the AIDS Drug Assistance Programs." The InfoGraphic provides graphical information on the state of coverage for ADAP, prior authorization data, and patient assistance program referral data.

CLICK HERE to download, "Hepatitis C Therapies Covered by the AIDS Drug Assistance Programs"

Black Market HIV/AIDS Drugs in the News, 2006 - 2013

The Partnership for Safe Medicines

The Community Access National Network (CANN) today announced that it is teaming up with the Partnership for Safe Medicines (PSM) to better educate patients about the risks of counterfeit or black market HIV/AIDS medicines. Since 2006, eighty-two (82) individuals have been charged with selling adulterated, unapproved or black market medications prescribed for HIV or AIDS patients.

CLICK HERE to download, "Black Market HIV/AIDS Drugs in the News, 2006 - 2013"

National ADAP Working Group (NAWG)

Hepatitis: Education, Advocacy & Leadership (HEAL)

Home  |  About Us  |  ADAP Watch  |  Co-Infection Watch  |  Medicaid Watch  |  Partners  |  Press Releases  |  Programs  |  Public Comments

For information regarding how the data collected by this Website is handled, please see our Privacy Policy.

© 2012-  - Community Access National Network (CANN)
Website by: DaveScans